Affiliation:
1. Wake Forest School of Medicine
2. Duke School of Medicine
3. University of Miami School of Medicine
Abstract
Abstract
Impulse Control Disorder (ICD) in Parkinson’s disease is a behavioral addiction induced by dopaminergic therapies, but otherwise unclear cognitive etiology. The current study investigates the influence of objective reward processing variables, dopaminergic therapy, and risky decision-making on ‘subjective feelings’ in patients with versus without ICD. Patients with (n = 18) and without (n = 12) a history of ICD secondary to Parkinson’s disease performed a risky decision-making task (on and off standard-of-care dopaminergic therapies). During the task, participants choose a ‘gamble’ or a ‘certain reward’ and report how they feel about decision outcomes. The subjective feeling of ‘pleasure’ is driven by different aspects of reward processing in patients with, versus without, a history of ICD. While off-medication, expectations about risky-decisions have a negative influence on subjective feelings in patients with a history of ICD versus a positive influence in patients without ICD. While on-medication, the influence of reward processing variables and recent experience on modulating subjective feelings in both patient groups are altered; patients with ICD become more emotionally reactive, whereas patients without ICD become less emotionally reactive. Computational modeling of risky decision-making behavior reveals latent factors that drive subjective feelings and risky behaviors in patients with versus without a history of ICD. Group differences are observed in off-medication states. Changes are induced in both groups with medication suggesting ICD-related decision-making may be driven by mechanisms associated with emotion regulation and that heightened dopaminergic processes may induce more reactive, less stable, emotion regulation in patients predisposed to developing ICD.
Publisher
Research Square Platform LLC